Nurse Practitioner in Lakewood, NJ Accepting Medicare
109 Nurse Practitioner nurses found. Showing 101 - 109
 Rivka Fligman, NP Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 1352 River Ave, Lakewood, NJ 08701 Phone: 732-370-5100 |
Kendie Castillo, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 101 2nd St, Lakewood, NJ 08701 Phone: 732-363-6655 |
Lina Perumpail, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 River Ave, Lakewood, NJ 08701 Phone: 732-363-1900 |
Pesha Miriam Cohen, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 456 Chestnut St, Suite 201, Lakewood, NJ 08701 Phone: 732-905-9200 Fax: 732-905-4470 |
Miriam Jurkowitz, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 500 River Ave Ste 245, Lakewood, NJ 08701 Phone: 732-901-8540 |
Maria Clarise Taguiam, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1255 Route 70 Ste 12n, Lakewood, NJ 08701 Phone: 732-942-0888 |
Bolanle Popoola, APN Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 399 Albert Ave, Lakewood, NJ 08701 Phone: 732-895-4733 |
Yehudis Rachel Finkelman, APN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 685 River Ave Unit 3, Lakewood, NJ 08701 Phone: 732-703-8405 |
Mrs. Tzivya Kownat, N.P. Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 23 Kedma Dr, Lakewood, NJ 08701 Phone: 732-942-3464 |
News Archive
SARS-CoV-2 detection with a simple, inexpensive, and sensitive molecular test
Researchers from the US recently described a rapid molecular test named WHotLAMP for the detection of SARS-CoV-2 in saliva. WHotLAMP is easy to use, very sensitive at 3.6 viral RNA copies per microliter of saliva, specific, and inexpensive. This study is published on the medRxiv*preprint serve.
Transgene raises €65.5M via two-step capital increase
Transgene SA, a French biopharmaceutical company focused on discovering, developing and manufacturing targeted immunotherapies for the treatment of cancer and infectious diseases, announces that it has raised a total of €65.5 million via a two-step capital increase.
Seropositive partners increase risk of COVID-19 but not obstetric complications in pregnant women
While earlier studies have shown the significance of serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pregnant women, their partners have largely been excluded. Now, a new Danish study published on the preprint server medRxiv in September 2020 reports the impact of serologic testing in both pregnant women and their partners, as well as their newborns.
Gene mutation discovery leads to novel treatment for patient with severe lymphatic condition
Faced with a preteen boy in pain and struggling to breathe from a severe, deteriorating rare condition, researchers at Children's Hospital of Philadelphia identified the responsible gene mutation and harnessed that knowledge to develop a novel treatment that dramatically improved the problem.
OICR invests $415,000 to develop radiolabelled insulin probe for early detection of breast cancer
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research today announced an investment of $415,000 towards the development of a radiolabelled insulin probe for the early detection of breast cancer.
› Verified 1 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Advanced Practice Midwife